USPTO serial 79392559
IDA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 16, 2025
- Examiner
- BURDECKI, ANNA C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IDA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebeccah Gan
Rebeccah Gan Muncy, Geissler, Olds & Lowe, P.C.125 S. Royal St.Alexandria, VA 22314United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Digital medical system comprised of downloadable and recorded software and downloadable and recorded software applications for computers and mobile devices for synchronizing and updating treatments, confirming prescriptions, and sending medical reminders and alerts; downloadable smartphone software applications linked to digital medical systems for synchronizing and updating treatments, confirming prescriptions, and sending medical reminders and alerts; downloadable and recorded computer application software for use on smartphones and personal electronic devices which are linked to digital medical systems for synchronizing and updating treatments, confirming prescriptions, sending medical reminders and alerts, and operating portable medical instruments; downloadable and recorded computer software for enabling access to online medical device statistics; downloadable computer applications for personally operating medical devices | ACTIVE | — |
| 010 | Medical devices, equipment and instruments, namely, for renal failure treatment; medical devices, equipment and instruments, namely, for dialysis patients home treatment for treating kidney failure | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 25, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 25, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 16, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 16, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 16, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 28, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 28, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 22, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 25, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 25, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 25, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 25, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 25, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 16, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 16, 2025 | ALIE | ASSIGNED TO LIE | — |
| Sep 12, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 9, 2025 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Aug 27, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 27, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 19, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Feb 18, 2025 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 18, 2025 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 18, 2025 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 10, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 10, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 1, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 9, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 9, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 27, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 26, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 5, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 1, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 28, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |